|
Canada-0-LinensRetail Azienda Directories
|
Azienda News:
- Treatment patterns and patient journey in progressive pulmonary . . .
Despite the poor prognosis and high mortality associated with PPF, approximately 15% of patients had never received treatment for ILD at the time of the survey
- Treatment patterns and patient journey in progressive pulmonary . . .
Despite the poor prognosis and high mortality associated with PPF, approximately 15% of patients had never received treatment for ILD at the time of the survey
- Plain language summary: patient journey and treatment patterns in . . .
This study aimed to better understand the patient journey and treatment patterns in people living with progressive pulmonary fibrosis (PPF) from five European countries
- Treatment patterns and patient journey in progressive pulmonary . . .
Overall, 17 4% of patients were misdiagnosed prior to ILD diagnosis, with chronic obstructive pulmonary disease suspected in 39 2% of them The most frequent comorbidities were anxiety (16 9%) and gastroesophageal reflux (15 5%)
- Treatment patterns and patient journey in progressive pulmonary . . .
There was a mean delay of 15 5 months between first ILD symptoms and ILD diagnosis Given the progressive nature of PPF, diagnostic delay may lead to poor outcomes, including shorter survival
- Patient journey in progressive pulmonary fibrosis (PPF) in Europe, USA . . .
Introduction: For patients (pts) with PPF not due to idiopathic pulmonary fibrosis, real-world data from first symptom to current management are limited Aims Objectives: Describe the diagnostic journey, treatment patterns, and burden of pts with PPF
- Treatment patterns and patient journey in progressive pulmonary . . .
Although 77 8% of patients were receiving treatment for ILD at survey date, 15 6% of patients had never been prescribed treatment for ILD This real-world study expands our understanding of patients, diagnostic delays and treatment gaps experienced by patients diagnosed with PPF in Europe
- Treatment patterns and patient journey in progressive pulmonary . . .
Although 77 8% of patients were receiving treatment for ILD at survey date, 15 6% of patients had never been prescribed treatment for ILD This real-world study expands our understanding of patients, diagnostic delays and treatment gaps experienced by patients diagnosed with PPF in Europe
- Treatment patterns and patient journey in progressive pulmonary . . .
For patients experiencing symptoms prior to ILD diagnosis (72 8%), the most common symptoms were dyspnoea on exertion (80 5%) and cough (57 8%) Overall, 17 4% of patients were misdiagnosed prior to ILD diagnosis, with chronic obstructive pulmonary disease suspected in 39 2% of them
- Patient Journey, Disease Burden and Treatment Paradigms in Patients . . .
Overall, 17 4% of patients were misdiagnosed prior to ILD diagnosis, with chronic obstructive pulmonary disease suspected in 39 2% of these patients Misdiagnosis rates varied by country, ranging from 12 7% in France to 21 4% in Italy
|
|